Skip to main content
logo
Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Jul 20, 2026

Nutra Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.320.390.390.590.440.1
Revenue Growth
-24.83%-1.75%-34.08%35.73%348.43%88.33%
Gross Profit
0.160.20.250.40.250.01
Operating Income
-1.49-1.46-0.88-0.89-1.91-1.99
Net Income
-1.1-2.05-1.29-1.398.18-13.1
Earnings Per Share
-0.00-0.00-0.00-0.000.00-0.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.040.030.050.0400.09
Total Debt
11.6911.359.969.318.558.4
Net Cash (Debt)
-11.65-11.32-9.91-9.27-8.55-8.3
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.00-0.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.09-1.16-0.42-0.55-0.76-1.74
Capital Expenditures
--0.03---0.06-0.04
Free Cash Flow
-1.09-1.19-0.42-0.55-0.82-1.78
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
48.42%51.03%63.07%66.64%56.82%8.66%
Operating Margin
-461.67%-379.52%-224.00%-149.10%-435.21%-2034.53%
Pretax Margin
-341.09%-531.37%-327.85%-234.22%1865.70%-13399.01%
Profit Margin
-341.09%-531.37%-327.85%-234.22%1865.70%-13399.01%
FCF Margin
-336.32%-308.85%-108.11%-92.46%-187.19%-1824.84%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----0.09-
PS Ratio
6.651.841.810.011.73149.92